Revvity, Inc. (NYSE:RVTY) Holdings Decreased by Quarry LP

Quarry LP decreased its position in shares of Revvity, Inc. (NYSE:RVTY) by 59.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 274 shares of the company’s stock after selling 406 shares during the period. Quarry LP’s holdings in Revvity were worth $29,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. UniSuper Management Pty Ltd increased its position in shares of Revvity by 505.2% in the first quarter. UniSuper Management Pty Ltd now owns 9,864 shares of the company’s stock worth $1,036,000 after acquiring an additional 8,234 shares in the last quarter. Entropy Technologies LP bought a new stake in Revvity during the first quarter worth approximately $480,000. Jane Street Group LLC boosted its holdings in shares of Revvity by 516.4% during the 1st quarter. Jane Street Group LLC now owns 453,343 shares of the company’s stock worth $47,601,000 after buying an additional 379,802 shares during the period. Quadrature Capital Ltd acquired a new stake in shares of Revvity in the first quarter valued at about $1,267,000. Finally, Royal London Asset Management Ltd. acquired a new position in shares of Revvity during the fourth quarter worth approximately $5,013,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Insider Activity

In related news, insider Joel S. Goldberg sold 3,500 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total value of $412,510.00. Following the transaction, the insider now owns 33,400 shares in the company, valued at $3,936,524. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

RVTY has been the subject of several research reports. TD Cowen increased their target price on shares of Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Wells Fargo & Company began coverage on Revvity in a report on Tuesday, August 27th. They set an “equal weight” rating and a $130.00 price objective on the stock. JPMorgan Chase & Co. raised their target price on Revvity from $105.00 to $120.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 30th. Leerink Partners started coverage on shares of Revvity in a report on Monday, July 8th. They set an “outperform” rating and a $125.00 price objective for the company. Finally, Bank of America upped their target price on shares of Revvity from $118.00 to $127.00 and gave the company a “neutral” rating in a research note on Tuesday, July 30th. Eight equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $125.53.

Revvity Price Performance

Shares of RVTY stock opened at $122.53 on Tuesday. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $128.15. The stock has a market capitalization of $15.12 billion, a PE ratio of 101.26, a PEG ratio of 2.90 and a beta of 1.05. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. The stock’s fifty day moving average is $121.74 and its 200-day moving average is $111.89.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, July 29th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The firm had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. During the same quarter in the prior year, the firm earned $1.21 EPS. The company’s revenue was down 2.5% on a year-over-year basis. Equities research analysts expect that Revvity, Inc. will post 4.75 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.23%. Revvity’s payout ratio is 23.14%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.